biomedical research

How does a biomedical sciences student with interests in clinical research go on to intern in the United States Senate? Like many other students, my undergraduate career followed a traditional path toward higher education. I kept my grades up, participated in extracurriculars, and was involved in a few clubs on campus. However, thanks to friends, mentors and the internet, it was clear that a career in STEM presented an immense number of other amazing opportunities. Looking into these opportunities, research quickly grabbed my attention. A professor was the first to introduce me to research and he motivated me to explore summer research opportunities. Looking back, I am grateful he did,...
Eradicating disease seems like an elusive pipe dream but not if you ask Donna Cryer , president and CEO of the Global Liver Institute. “9,000 days ago, doctors told me I had seven days to live,” said Cryer. “I believe in our ability to continually adapt and innovate and conquer disease”. Cryer was joined by Research!America board member Dr. William Hait, global head, Janssen Research and Development, and fellow board member Dr. Mark McClellan, director, Duke-Robert J. Margolis Center for Health Policy, Duke University for an interactive panel discussion titled, A World Without Disease: Can We Get There? , at the BIO International Conference in San Diego, California on June 20. Research!...
Research!America will host an interactive panel discussion on June 20 titled, A World Without Disease: Can We Get There? , at the BIO International Convention in San Diego, California. During the session, experts from the regulatory, pharmaceutical, and advocacy sectors will discuss the implications of new technologies and the challenges of leveraging limited resources to maximize patient benefit. Research!America’s session will seek to address the question, “how can we capitalize on insights from the biotechnology industry and facilitate a coordinated effort to eradicate disease?”. To do so, Research!America board member William Hait, M.D., Ph.D. , global head at Janssen Research and...
Tweet Follow @ResearchAmerica Six science-savvy teams comprised of researchers from around the globe are currently in the running for a grand prize of $230,000 to develop new big data methods for advancing biomedical research. The two-phased Open Science Prize contest was made possible through a collaboration between the National Institutes of Health (NIH) , the Wellcome Trust and the Howard Hughes Medical Institute . During the first phase, the teams received prize money to help create tools or services that could be used to tackle important issues in biomedicine and improve health. They designed prototypes to address subjects such as neuroimaging, rare diseases, mental and neurological...
What, in y our view, are the major challenges facing our nation’s research enterprise? Biomedical research is the driving force behind decades of advances that have improved the health of people in every corner of America—including the lives of those affected by breast cancer. With a robust and sustained investment in biomedical research, the possibilities would be endless. The National Institutes of Health (NIH) and its National Cancer Institute (NCI) have played a role in every major cancer prevention, detection and treatment advance in breast cancer for decades. Within the NIH, the NCI is the principal agency for cancer research and training. The NCI has funded numerous major breast...
Watch the videos from each panel, read the transcript , view the photo gallery and read the WebMD live recap . “The biomedical research enterprise underpins the health of the nation and much of the world, and is in dire need of substantial infusion to meet the great medical needs of our time,” said William N. Hait, M.D., Ph.D. , global head, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, the keynote speaker at the 2016 National Health Research Forum, added that we’re losing time in addressing threats like the Zika virus, Ebola and cancer while waiting for funding to improve for biomedical research. The program, held Thursday,...
More than 100 million Americans live with the devastating effects of a debilitating neurological or psychiatric disease each year. In addition to producing severe hardship for millions of families, such suffering costs the U.S. economy at least $760 billion annually. The Society for Neuroscience (SfN), the world’s largest organization of scientists and physicians devoted to understanding the brain and nervous system, believes that the only way to foster the scientific breakthroughs needed to alleviate that suffering is with strong, consistent and reliable public funding of biomedical research through agencies including the National Institutes of Health (NIH) and the National Science...
Elected officials, business leaders, university presidents from across the state, leaders of biotech companies and nationally-ranked medical centers, and research scientists came together to discuss public-private partnerships and other initiatives that maximize the impact of medical research on the local and national economy, and benefit the health of citizens. Research!America and Northeast Ohio Medical University co-hosted the forum, “Medical Research: The Right Prescription for Economic Growth,” at the NEOMED Education and Wellness Center in Rootstown, Ohio on June 6. “Federal investment in R&D, especially basic research, is critical to success, and is a good thing for our economy...
This op-ed appeared online on Roll Call July 31, 2015. New technology such as CRISPR-Cas9, a genuine scientific breakthrough, is raising hope for patients with cancer, cystic fibrosis, sickle-cell anemia and other major health threats. The gene editing tool, used in precision medicine, allows changes to be introduced into the DNA of any living cell— potentially enabling repair of disease causing mutations, neutralization of disease carrying insects, and much more. This technology, developed with support from the National Institutes of Health (NIH) and National Science Foundation (NSF), is an example of the realization of the promise of innovative research funded by our federal science...
Today is a social media Day of Action for Research!America and our #FindFundCure campaign. Join us all day on Twitter and Facebook by using the hashtag #findfundcure and make your voice heard. While Congress debates its budget for the upcoming fiscal year, we will advocate for accelerated progress in biomedical innovation by pressing for more research funding. Join us and share personal stories, relevant data, and compelling visuals to make the case that insufficient funding costs lives. It’s time to find the money, fund the research, and cure the disease! Spread the word and share our Day of Action toolkit , complete with sample messages and resource links, with your professional and...

Pages

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America